PD-L1 antibody
-
- Target See all PD-L1 Antibodies
- PD-L1 (CD274 (PD-L1))
-
Reactivity
- Human
-
Host
- Goat
-
Conjugate
- This PD-L1 antibody is un-conjugated
- Application
- Please inquire
- Cross-Reactivity
- Human
- Characteristics
- Goat Anti-CD274 / PD-L1
- Immunogen
- Peptide with sequence CKKQSDTHLEET, from the C Terminus of the protein sequence according to NP_054862.1.
- Top Product
- Discover our top product PD-L1 Primary Antibody
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
-
- Target
- PD-L1 (CD274 (PD-L1))
- Alternative Name
- CD274 / PD-L1 (PD-L1 Products)
- Synonyms
- B7-H antibody, B7H1 antibody, PD-L1 antibody, PDCD1L1 antibody, PDCD1LG1 antibody, PDL1 antibody, A530045L16Rik antibody, B7h1 antibody, Pdcd1l1 antibody, Pdcd1lg1 antibody, Pdl1 antibody, RGD1566211 antibody, CD274 molecule antibody, CD274 antigen antibody, programmed cell death 1 ligand 2 antibody, CD274 antibody, Cd274 antibody, PDCD1LG2 antibody
- Background
- Synonyms: CD274, CD274 antigen, PD-L1, PDCD1LG1, B7-H, B7H1, PDL1, PDCD1L1, programmed cell death 1 ligand 1, PDL1, HGNC:17635, CD274 molecule, MGC142294, MGC142296
- NCBI Accession
- NP_054862
- Pathways
- Cancer Immune Checkpoints
-